Abbott Laboratories | Patient Daily

Abbott Laboratories

Patient Daily Report | May 22, 2023

Dr. Lakkireddy: 'Assert-IQ ICM is a significant advancement amongst the tools that are currently available for diagnoses of irregular heart rhythms'

Press release submission | Oct 26, 2018

ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Press release submission | Oct 18, 2018

ABBOTT: New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care

Marian Johns | Nov 17, 2017

Abbott receives approval in Japan for device to treat mitral regurgitation heart disease

Carol Ostrow | Nov 3, 2017

XIENCE implants show benefits in cardiac recovery

Mark Iandolo | Oct 26, 2017

Abbott rolls out new DRG Neurostimulator System to help combat chronic pain

Kathy Adams | Oct 6, 2017

Abbott completes acquisition of Alere

Carol Ostrow | Oct 3, 2017

Freestyle Libre gains FDA approval, ending need to prick finger for glucose testing, Abbott says

Trending

Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'

Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'

+ Pharmaceuticals

Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’